BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Manufacturing

WuXi Biologics Reports Remarkable 2022 Annual Results

2022 Financial Highlights Revenue: The Group's revenue increased to RMB15,268.7 million with an increase of 48.4% y-o-y. The increase was...

March 23, 2023 | News

Remedium and Exothera partner on scale-up and demonstration runs for AAV2-FGF18

Remedium’s lead candidate is the only disease modifying gene therapy based on the clinically proven regenerative mechanism of FGF18. OA is the larges...

March 22, 2023 | News

3SBio Reports 7.5% YoY Revenue Growth and 25.2% Jump in Profit for 2022

New drugs started to embrace a commercialization wave, and license-out and license-in partnerships geared up. Revenue in 2022 increased by 7.5% year on yea...

March 22, 2023 | News

Hovione and Ripple Partner to Expand Epidel® Platform Beyond Ophthalmology.

The core feature of Ripple's Epidel® technology is the ability to deliver sustained-release pharmaceuticals with surface erosion release kinetics witho...

March 21, 2023 | News

Samsung Biologics to build Plant 5 for Bio Campus II expansion.

The company plans to begin construction in the first half of 2023 and commence operations in 2025 As part of Samsung Biologics' second Bio Campus, ...

March 17, 2023 | News

Vetter strengthens worldwide commitment to sustainable business practices

Globally, Vetter is one of over 300 companies in the pharma and biotech industrythat have signed the UN Global Compact Membership drives expansion of ec...

March 08, 2023 | News

GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS

GenScript ProBio extends congratulations on this. 2 years ago, GenScript ProBio and Eutilex announced that the parties entered into strategic collaboration...

March 07, 2023 | News

ExoCoBio Obtains GMP Licenses for Exosome Biopharmaceuticals and HA Dermal Fillers

ExoGMP™ is the world's largest exosome manufacturing facility in Osong, South Korea. Cellosome™ HA fillers are expected to be approved ...

March 02, 2023 | News

Manufacturing ROI Calculator - How Much Can Manufacturing Excellence Save Your Organisation?

Most manufacturers know that paper or disconnected systems on the factory floor make manufacturing operations slower and more prone to error, but the pai...

March 02, 2023 | News

AtomVie Global Radiopharma builds industry-leading CDMO facility in Ontario.

Currently located on the McMaster University campus, AtomVie successfully operates a global leading Contract Development and Manufacturing Organi...

March 02, 2023 | News

Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform

Porton Advanced CDMO offers end-to-end gene and cell therapy services covering plasmids, cell therapy, gene therapy, oncolytic virus, mRNA therapy, and bac...

February 27, 2023 | News

GenScript ProBio and RVAC Medicines Partner for COVID-19 Vaccine Plasmid DNA Manufacturing

GenScript ProBio will provide GMP plasmid manufacturing service for RVAC Medicines' program, RVM-V001. This partnership will enable to accelerate its clini...

February 23, 2023 | News

Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities

The investment has also increased the facility’s capabilities to support larger packaging campaigns through the addition of specialized secondary pac...

February 15, 2023 | News

AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva

AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply c...

February 10, 2023 | News

Stay Connected